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Summary
Objective: The purpose of this study was to develop and validate a disease-specific quality of life measurement tool for osteoarthritis (OA)
of the shoulder.
Methods: An instrument which could be used as the primary outcome measure in clinical trials involving patients with OA of the shoulder was
developed using a specific methodological protocol: (1) identification of a specific patient population; (2) item generation; (3) item reduction;
(4) pre-testing of the prototype questionnaire and (5) determining the validity, reliability and responsiveness of the final questionnaire.
Results: The final instrument contains 19 items, each with a visual analog response option for the four domains (six questions for pain and
physical symptoms, five questions for sport, recreation and work, five questions for lifestyle function and three questions for emotional
function). Ten of the 19 questions had not been identified previously on other shoulder measurement tools. The instrument proved to be valid
by demonstrating predicted correlations with previously published shoulder measures, global health status measure and range of motion.
The new instrument was also more responsive than other shoulder measurement tools, a global health status measure and range of motion.
Conclusions: Since the patient’s own perception of changes in health status is the most important indicator of the success of treatment we
suggest that this measurement tool be used as the primary outcome in clinical evaluation of various treatments for OA of the shoulder and
monitoring patients over time. © 2001 OsteoArthritis Research Society International
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Osteoarthritis (OA) is a common disease of great economic
importance and its burden on mankind is increasing in step
with the aging of the population1. OA of the shoulder,
although not as prevalent when compared with the hip or
knee, has been demonstrated in cadaveric studies to affect
28.6% of patients greater than 60 years of age2. It is
estimated that over 10,000 shoulder arthroplasties are
performed each year in the United States alone3.
A wide range of treatment modalities is available includ-
ing analgesics, non-steroidal antiinflammatory drugs,
physiotherapy, arthroscopic debridement, arthrodesis,
resection arthroplasty and shoulder arthroplasty4. All of
these interventions are designed to improve a patient’s
quality of life and yet a validated, disease-specific quality of
life measurement tool is not available to assess the benefit
of such interventions5.
Thus, the purpose of this study was to develop a
measurement tool that was valid, reproducible, responsive
and user friendly for the assessment of quality of life as it
pertains to the shoulder in patients with OA of the shoulder.
Since it is the patient’s subjective impression of their health771status that is most important to the success of treatment it
was decided that a disease-specific quality of life measure-
ment tool would be most appropriate. This tool was
designed to be used as the primary outcome measure in
clinical trials evaluating the treatment of patients with OA of
the shoulder or to be used by clinicians for ongoing
evaluation of patients in their practice.Methods
The method for developing quality of life measurement
tools has been well defined by Kirshner and Guyatt6 and
has previously been published for the development of a tool
for patients with instability of the shoulder7. The five major
steps include (1) identification of a specific patient popula-
tion, (2) item generation, (3) item reduction, (4) pre-testing
the prototype instrument and (5) determining the validity,
reliability and responsiveness of the instrument.Received 15 August 2000; revision requested 17 November
2000; revision received 28 March 2001; accepted 9 July 2001.
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This work was supported by a grant from 3M Canada.(1) POPULATION IDENTIFICATION
The purpose of this instrument is to evaluate the disease
specific quality of life of patients with symptomatic OA of the
shoulder. Thus, the target population was patients of all
ages with a diagnosis of primary OA of the shoulder. The
diagnosis of primary OA was defined as:
(1) Chronic progressive shoulder pain.
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Item generation is considered the most important step in
the development of a disease specific quality of life
measurement tool. This step must be comprehensive since
the final measurement tool can only consist of the specific
items identified in this stage.
Since the ultimate goal of the final measurement tool
is to measure health related quality of life, a comprehen-
sive definition of health was chosen. The World Health
Organization defines health as ‘a state of complete physi-
cal, mental and social well-being’8. We therefore included
five domains encompassing all aspects of health including:
(1) pain and physical symptoms, (2) sports and recreation,
and work function, (3) social function and (4) emotional
function8.
The item generation was carried out in three steps as
previously published7. In the first step, a review of the
literature was conducted to identify items that would be
appropriate from descriptions of the syndrome of OA of the
shoulder, from global health measurement tools (Index of
Well-Being9, Sickness Impact Profile10, SF-3611), from
disease specific questionnaires in related areas (Arthritis
Impact Measurement Scale12), and existing instruments
specific to the shoulder (Constant score13, UCLA shoulder
scale14, American Shoulder and Elbow Surgeon’s
Evaluation Form15). In addition, items were identified from
the unpublished shoulder rating scales of colleagues with
an interest in shoulder surgery.
In the second step, orthopedic surgeons and physio-
therapists with interest in the treatment of OA of the
shoulder were interviewed. Participants were asked to
identify the most important patient symptoms for each
domain using open-ended questions in an interview setting.In the final and most important step, patients with OA of
the shoulder were interviewed. Patients were selected with
a wide spectrum of patient characteristics, disease severity,
and treatments to ensure that the entire spectrum of
symptomatology would be elicited.
Patients signed an informed consent to participate in the
study. Patients then underwent a semi-structured interview
by a research assistant (SG) with expertise in the develop-
ment in quality of life measurement tools7. During the
interview, patients were asked to identify any items that
contributed to their shoulder functioning less than perfectly.
Patients were then asked specifically about each of the five
domains. At the end of the interview a spouse or significant
other was invited to identify any items that the subject may
have omitted. New subjects were interviewed until no new
items had been identified with five consecutive interviews,
a technique termed ‘interviewing to redundancy’16. As a
result, a total of 20 patients were interviewed. There were
nine females and 11 males and the patients’ ages ranged
from 38 to 89 (mean 66.2 years). Seven had undergone
arthroplasty surgery, three arthroscopy and debridement,
eight were undergoing combinations of non-surgical treat-
ment which included cortisone injections, physiotherapy
and NSAIDs and two had had no treatment at the time of
the interview. By the end of this step 199 items were
identified.(3) ITEM REDUCTION
Item reduction involves determining which items should
be retained on the final measurement tool. Obviously, a
questionnaire with close to 200 items would be clinically
impractical. Therefore, the goal is to retain 20–30 items that
are most important to the patients and are representative of
the total concept of health-related quality of life. Item
reduction was carried out in three stages as previously
published6,7.
The investigators reviewed each item and eliminated
items that were duplicated or incomprehensible. Each item
was restructured to a grade 8 reading level. Items were
screened to remove any ambiguity, jargon or value-laden
wording and double-barreled questions16. Any items which
could not change following treatment were also discarded.
Seventy-one items remained at this point.
This questionnaire of 71 items was then administered to
100 new patients (not previously involved in item genera-
tion) selected from the database who again represented
the full spectrum of patients. For each item, subjects were
asked to assess whether they experienced the item or not.
If the item was experienced, they were further asked to rate
the importance of the item to their overall shoulder func-
tioning. The importance was ranked on a scale of 1 (not
important) to 5 (extremely important).
The frequency with which each item was experienced
and the mean importance were calculated for each item17.
The frequency importance product (frequency×mean
importance) was then generated for each item.
The top 50 items based on the frequency importance
product (FIP) were then subjected to further analysis. Each
question was correlated with every other question and also
correlated with the grouped questions in its domain. This
allowed us to eliminate questions that were highly corre-
lated (r2=0.58–0.999) and were therefore measuring the
same concept.(2) Radiographic evidence demonstrating all of the fol-
lowing: joint space narrowing, osteophyte formation
and subchondral sclerosis.
Patient exclusion criteria included:
(1) Large or massive rotator cuff tears and rotator cuff
arthropathy.
(2) Language, psychiatric, or cognitive difficulties that
prevented reliable completion of interviews or
questionnaires.
(3) A diagnosis other than shoulder OA that would signifi-
cantly contribute to the patient’s shoulder dysfunction
(such as cervical spine disease, weakness relating to
neurologic condition).
(4) Another major illness, which substantially influenced
the patient’s quality of life (i.e. unstable angina).
(5) History of significant shoulder trauma, infection,
avascular necrosis, cuff tear arthropathy, chronic
dislocation, or secondary cause of OA.
Since the final instrument could potentially be used in
evaluating all non-operative and operative treatments,
patients were included who had received no treatment
or any combination of physiotherapy, oral medications,
injections or operative treatments.
From the files of three participating orthopedic surgeons,
a database of 150 patients meeting the inclusion criteria
was established. Charts were reviewed and data collected
to ensure that patients met the inclusion and exclusion
criteria. Data were collected on the patients’ age, gender,
treatments to date and their overall assessment of the
severity of their disability.
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Pre-testing the prototype questionnaire is conducted to
ensure that the wording is clear and that patients interpret
the items as they are intended. The questionnaire was
administered to two groups of 10 subjects not previously
involved in the development of the tool. Subjects were
asked to complete the questionnaire and then to give their
interpretation of each item, to identify any questions with
unclear wording, and finally to give their opinion as to
whether there were any omissions from the questionnaire.
Changes were made to the questionnaire after the first set
of 10 patients but no further modifications were necessary
after the second set of patients.ITEM SCALING AND WEIGHTING
In general, two methods exist for quantifying an individ-
ual’s response to a specific item: multi-item Likert scales
(i.e. no pain, a little pain, moderate pain, a great deal of
pain) and visual analog scales (100 mm lines anchored at
either end by the extremes of the dimension being
measured—no pain, extreme pain—along which the sub-
jects are asked to place a mark to indicate their status)18.
We have found it difficult to construct Likert scales
that are consistent, meaningful and evenly spaced and,
therefore, the visual analog scale was used for this tool7,18.
It is also controversial as to how the individual items
within an instrument should be weighted. In some instru-
ments the author who has devised the instrument has
arbitrarily chosen some items to be more important than
others and therefore has given them more weight13,14.
It would be possible to weight the items according to the
mean importance or the FIP. The FIPs, for the question-
naire of 71 items ranged from 29 to 206. The final 19 items,
however, had a narrow range from 142 to 206. Since the
items on the final tool had consistently high FIPs falling
within a narrow range, we decided to give all the items the
same weight7,19. Therefore, in the final instrument, each
question has a possible score from 0–100 (100 mm VAS)
and is not multiplied by any factor because of the equal
weighting. These scores are added to give a total score
of 1900. The raw score can then be converted to a
percentage score.(5) VALIDITY, RELIABILITY AND RESPONSIVENESSValidity
A tool is considered valid if it is measuring what it is
supposed to measure20. However, a ‘gold standard’ by
which to determine this does not exist for quality of life.
Therefore we must rely on construct validation, which tests
the hypothesis that the questionnaire behaves in relation to
other measures as would be expected if it were measuring
quality of life. This is accomplished by making a priori
predictions regarding the correlation of the questionnaire
with other related measures at one point in time for evalu-
ating the discriminative characteristics of the tools and the
change in scores over time for evaluating the evaluative
characteristics of the tools. A discriminative index is used to
distinguish between individuals or groups with respect to an
underlying condition whereas an evaluative index is used to
measure the magnitude of longitudinal change in an indi-
vidual or group21.
The new measurement tool and other measurement
tools (Constant Score13, UCLA Shoulder Rating Scale14,
American Shoulder and Elbow Surgeons Standardized
Shoulder Assessment Form (ASES)15, SF12 global health
instrument11, range of motion11, global change rating scale
(Appendix B) were administered on two occasions to a
group of 41 patients selected from the database who were
undergoing treatment for OA of the shoulder. (Some of
these patients were involved in another step of the devel-
opment of the tool.) Correlations of the baseline and
change scores were determined by the Pearson product–
moment correlation. The a priori predictions of the correla-
tions for baseline and change scores were made giving
careful consideration to the content and weighting of the
various tools and how they have behaved in published
studies and are presented in Table I.Table I
Construct validation showing correlations between the WOOS and other outcome measures
Outcome measure Pearson product–moment correlation
Baseline Change score
r, A priori
prediction
r
Actual
r, A priori
prediction
r
Actual
UCLA shoulder rating scale 0.5 0.630 0.5 0.604
Constant score 0.6 0.730 0.6 0.685
Global change N/A N/A 0.5 0.475
ASES 0.5 0.590 0.5 0.425
McGill pain questionnaire 0.4 0.578 0.4 0.536
McGill VAS 0.4 0.407 0.4 0.218
SF12 physical score 0.5 0.650 0.4 0.287
SF12 mental score 0.3 0.460 0.2 0.159
Range of motion 0.3 0.607 0.2 0.545
N/A: not applicable.Reliability
Reliability encompasses the concept that repeated
administration of a measurement tool in stable subjects will
yield the same results. The reliability of the measurement
tool was evaluated in 58 patients over a 3-month period.
This interval was chosen since it represents a common
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Because it was possible for patients to change over
3 months of time, a global rating of change questionnaire
(Appendix 1) was concurrently administered to the sub-
jects. Subjects who reported no change were considered
stable and those who reported change were eliminated
from this analysis.
Intraclass correlation coefficient is considered to be the
preferable index of reliability and was calculated from a
one-way random effects analysis of variance22–25.Responsiveness
A group of 41 patients, who were involved in a random-
ized clinical trial comparing hemiarthroplasty with total
shoulder arthroplasty in primary OA of the shoulder and
therefore were expected to change between testings, were
evaluated. These patients were evaluated pre-operatively
(baseline) and 3 months post-operatively.
Several methods have been described for determining
the responsiveness of a tool20,26–28. In this case the
standardized response mean28 was chosen since it corre-
lates with the power of a test and therefore is most relevant
when designing clinical trials. The standardized response
mean is calculated by dividing the mean change in score by
the standard deviation of the change scores28.Results
The final instrument has 19 items, representing the four
domains (six questions for pain and physical symptoms,
five questions for sport, recreation and work function, five
questions for lifestyle function and three questions for
emotional function (Appendix 2)). The response time is
approximately 10 min.
The highest or most symptomatic score is 1900 and the
best or asymptomatic score is 0. In order to present this in
a clinically more meaningful format, the score can be
reported as a percentage of normal by subtracting the total
from 1900, dividing by 1900 and multiplying by 100. As an
example, a patient with a total score of 450 would have a
percentage score of
The instrument contains specific instructions to be read
by the subjects prior to beginning and a supplement to the
instrument may be referred to if patients are unsure of the
meaning of any question. The instrument also has specific
instructions to the clinician on how it should be scored.
These features allow for a more consistent presentation to
all subjects and evaluations can be done by mail when
necessary. Thus, results using this measurement tool may
be compared between centres.
The correlation between the WOOS and each of the
other measurement tools for construct validation is sum-
marized in Table I. As predicted all the actual correlations
were within 0.2 of the a priori predictions.
As a discriminative instrument, the WOOS correlated
most strongly with the Constant Score (r=0.685) and
lowest with the SF12 mental score (r=0.159). As an evalu-
ative instrument it also correlated best with the Constant
Score (r=0.73) and lowest with the SF12 mental score
(r=0.460).Of the 58 patients evaluated for reliability, 22 remained
stable (as measured by a global rating of change (Appendix
1)) over a 3-month period. The WOOS total score and
each of the domains had excellent reliability (intraclass
correlation coefficient >0.75) (Table II)25,30.
Data on responsiveness revealed (Table III) that the
WOOS was more sensitive for detecting change over time
than the other measurement tools. The SF 12 mental score
was the least responsive.Table II
Reliability of the WOOS and its domains as shown by intraclass
correlation coefficients at 3 months after original administration of
the WOOS
Domain Intraclass correlation
coefficient (r)
WOOS total score 0.964
Physical symptoms 0.946
Sports/recreation/work 0.939
Lifestyle 0.869
Emotions 0.907Table III
The standardized response mean of the outcome measures tested
Outcome measure Standardized
response
mean
WOOS 1.910
McGill VAS 1.710
UCLA shoulder rating scale 1.370
ASES 1.290
McGill Pain 1.240
Constant score 1.210
SF 12 physical score 0.970
Range of motion 0.720
SF12 mental score 0.430Discussion
It is estimated that over 10,000 shoulder arthroplasties
are performed annually in the United States and that the
number will continue to increase dramatically in the near
future3. Total shoulder arthroplasty has been shown to be
as cost effective as total hip or knee arthroplasty in improv-
ing quality of life (when using the method of quality adjusted
life years)31.
Most orthopedic interventions are designed to improve a
patient’s quality of life (morbidity) and yet a disease-specific
quality of life measurement tool is not available to assess
the benefit of such interventions in the shoulder OA
population.
Global health-related quality of life measurement tools
have been developed for the general population such as
the Index of Well-Being9, Sickness Impact Profile11, and
the SF1211. However, these tools are poor at detecting
small but clinically important changes in quality of life of
patients with specific medical conditions. Therefore,
disease-specific measurement tools have been developed.
As an example, the Western Ontario McMaster Arthritis
Index (WOMAC)32, a disease-specific tool, was developed
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subsequently been shown to be the most responsive of all
currently available tools for measuring the outcome follow-
ing total knee replacement33. A highly responsive measure-
ment tool may decrease costs in clinical trials since it allows
for smaller sample sizes to identify clinically relevant differ-
ences and is more likely to be useful in making treatment
decisions in individual patients in clinical practice.
The three most commonly used functional rating scales
for studies evaluating patients with OA of the shoulder are
the UCLA shoulder rating scale14, the Constant score13
and the American Shoulder and Elbow Surgeons (ASES)
evaluation form15. Each of these scales provide gauges
by which to document improvement following treatment.
However, none is specific for OA of the shoulder.
The questions in the subjective portion of these tools
were generated by experts as opposed to patients and,
therefore, the items included in the measurement tools are
those the clinicians deem important and not necessarily
those that are important to patients. It is not clear how the
weighting of the items has been decided. In a study
involving patients with shoulder disorders, Lirette et al.34
demonstrated that by using different physician generated
scales and different accepted criteria for a ‘satisfactory’
result, the proportion of ‘satisfactory’ results ranged from
37% to 80%.
In addition, what may be a documented change in
questionnaire scoring may not prove to be a significant
clinical change or an improvement in quality of life (particu-
larly in physician generated scales). Many of these scales
require clinical evaluations of the patients by a physician. It
has been shown that clinical examination variables (i.e.
range of motion), even when carried out by experienced
clinicians, have very poor reliability35 and correlate poorly
with patients’ subjective evaluations of their function20. In
addition, it has been well documented that physicians tend
to evaluate their patients as functioning better than the
patients perceive themselves to be36.
When comparing previous scales to the WOOS, 10 of
the 19 items were not identified in any of the three pre-
viously published scales despite these items being consid-
ered to be among the 19 most frequently experienced and
most important items to patients with OA of the shoulder.
For example, ‘How much is your shoulder affected by the
weather?’ and ‘How much difficulty do you experience
reaching behind to tuck in a shirt, get a wallet from your
back pocket or do up clothing because of your shoulder?’ In
addition, most scales do not have any questions about the
domains of lifestyle and emotional function, making them
less comprehensive for the evaluation of total health.
Validating a disease-specific quality of life measure-
ment tool is an ongoing process. Since there is no ‘gold
standard’ with which to compare, we must rely on
construct validation.
The WOOS correlated moderately well with the Constant
score13 and the UCLA shoulder rating scale14, which would
be expected since these are joint-specific outcome tools.
When assessing the reliability of an instrument, the intra-
class correlation coefficient is the preferable statistical
test22–25. However, there is no consensus on the accept-
able degree of reliability. In general, the acceptable reliabil-
ity for interpreting scores for individuals37,38 ranges from
0.85 to 0.94 and the acceptable reliability for describing
groups is lower (0.75)16,30. The WOOS, with an intraclass
correlation coefficient of 0.964, is therefore adequate for
use in both the research setting, where conclusions would
be drawn based on mean scores from a group of patients,and also in the clinical setting for monitoring an individual
patient’s progress and potentially using the results to aid in
clinical decision making.
The WOOS also proved to be highly responsive and had
the highest standardized response mean of those tested. A
highly responsive measurement tool has two major advan-
tages. Highly responsive tools are best able to identify
small, but clinically important, changes following an inter-
vention, making them most useful for monitoring patients in
the clinical setting. In addition, such tools may decrease
costs in clinical trials since a more responsive tool allows
for smaller sample sizes in order to identify clinically
significant differences. For example, when comparing the
WOOS to ASES, we can see that the WOOS would require
approximately 35% fewer subjects than ASES to detect the
same amount of change (square of the ratio of standard-
ized response mean=(1.158/0.996)2=1.35).
There are now several ‘outcome’ tools available to
choose from when evaluating patients with shoulder
disorders7,9–15,32,39–41. One needs to select the most
appropriate tool for the task required. It is certainly con-
venient to use global health tools but they are of little
clinical usefulness because most of the items are not
relevant to the patient’s condition and they are insensitive
to change. However, these tools are useful for comparing
across diseases (i.e., effectiveness of Coronary Artery
Bypass Graft vs Total Knee Arthroplasty). Joint-specific
tools are the middle ground; practical for monitoring and
retrospective reviews. Finally, disease-specific tools are
best for clinical trials and for monitoring and clinical deci-
sion making with individual patients. For example, if one
wishes to determine and compare the overall shoulder
function of several different patient populations with
different shoulder disorders and treatments, then perhaps
a general shoulder function questionnaire such as the
Shoulder Rating Scale41 should be included as an outcome
measure. However, if one is conducting a clinical trial and
wishes to determine if there a difference in quality of
life outcome in osteoarthritic patients treated with total
shoulder vs hemiarthroplasty, then a highly responsive
disease-specific quality of life outcome measure such as
the WOOS is most appropriate.Conclusion
The WOOS is a rigorously designed measurement tool
for patients with OA of the shoulder that is valid, reliable
and highly responsive. Since the patient’s own perception
of changes in health status is the most important indicator
of the success of treatment, we suggest that this measure-
ment tool may be used as the primary outcome in clinical
trials of treatments in this patient population. Its properties
also allow it to be used in the clinical setting.References
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A: Overall how is your shoulder compared to 3 months
ago?
Better h
Same h
Worse h
If you are feeling better or worse, how much better or
worse do you feel?
Very little difference h
A little different h
Somewhat different h
A good deal different h
A great deal different h
*B: Considering your Physical Symptoms:
How is your shoulder compared to 3 months ago?
Better h
Same h
Worse h
If you are feeling better or worse, how much better or
worse do you feel?
Very little difference h
A little different h
Somewhat different h
A good deal different h
A great deal different h
*The same scale was administered for each domain (Sports/
recreation/work, Lifestyle, Emotions).Appendix 2*: The Western Ontario Arthritis of
the Shoulder (WOOS) Index
SECTION A: Physical Symptoms
INSTRUCTIONS TO PATIENTS
The following questions concern the physical symptoms
you have experienced due to your shoulder problem. In all
cases, please enter the amount of the symptom you have
experienced in the last week. (Please mark your answers
with a slash ‘‘/’’.)
1. How much pain do you experience in your shoulder with
movement?
no extreme
pain pain
2. How much constant, nagging pain do you have in your
shoulder?
no extreme
pain pain
*On the actual form the lines are 100-mm long.
This form is reproduced by permission of the Fowler Kennedy
Sport Medicine Clinic.3. How much weakness do you experience in your
shoulder?
no extreme
weakness weakness
4. How much stiffness do you experience in your shoulder?
no extreme
stiffness stiffness
5. How much grinding do you experience in your shoulder?
none extreme
6. How much is your shoulder affected by the weather?
no extremely
affected affected
SECTION B: Sports/Recreation/Work
INSTRUCTIONS TO PATIENTS
The following section concerns how your shoulder problem
has affected your sports or recreational activities in the past
week. For each question, please mark your answers with a
slash ‘‘/’’.
7. How much difficulty do you experience working or
reaching above shoulder level?
no extreme
difficulty difficulty
8. How much difficulty do you experience with lifting objects
(eg. grocery bags, garbage can etc.) below shoulder level?
no extreme
difficulty difficulty
9. How much difficulty do you experience doing repetitive
motions below shoulder level such as raking, sweeping or
washing floors because of your shoulder?
no extreme
difficulty difficulty
10. How much difficulty do you experience pushing or
pulling forcefully because of your shoulder?
no extreme
difficulty difficulty
11. How troubled are you by an increase in pain in your
shoulder after activities?
not at all extremely troubled
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INSTRUCTIONS TO PATIENTS
The following section concerns the amount that your
shoulder problem has affected or changed your lifestyle.
Again, please indicate the appropriate amount for the past
week with a slash ‘‘/’’.
12. How much difficulty do you have sleeping because of
your shoulder?
no extreme
difficulty difficulty
13. How much difficulty have you experienced with styling
your hair because of your shoulder?
no extreme
difficulty difficulty
14. How much difficulty do you have maintaining your
desired level of fitness because of your shoulder?
no extreme
difficulty difficulty
15. How much difficulty do you experience reaching behind
to tuck in a shirt, get a wallet from your back pocket or do
up clothing because of your shoulder?
no extreme
difficulty difficulty16. How much difficulty do you have dressing or
undressing?
no extreme
difficulty difficulty
SECTION D: Emotions
INSTRUCTIONS TO PATIENTS
The following questions relate to how you have felt in the
past week with regard to your shoulder problem. Please
indicate your answer with a slash ‘‘/’’.
17. How much frustration or discouragement do you feel
because of your shoulder?
no extreme
frustration frustration
18. How worried are you about what will happen to your
shoulder in the future?
not extremely
worried at all worried
19. How much of a burden do you feel you are on others?
not at extreme
all burden
